News Quantified

KRYS – krystal biotech, inc. (US:NASDAQ)

Assessing Krystal Biotech (KRYS) Valuation After Recent Share Price Weakness [Yahoo! Finance]

3/29

08:27 am

krys

Low

MRNA, SRPT, and KRYS Phase 3 Data Will Shape XBI's 2026 Performance [Yahoo! Finance]

Krystal Biotech (KRYS) is now covered by Wolfe Research. They set a "peer perform" rating on the stock.

Krystal Biotech (KRYS) was downgraded by Weiss Ratings from "buy (b-)" to "hold (c+)".

Updated YJUVEK Label and KB803 Progress Could Be A Game Changer For Krystal Biotech (KRYS) [Yahoo! Finance]

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}